# Sprint 12 synthetic completion-prerequisites review evidence packet

Status: Bounded automated evidence passing; independent reviews and program-owner packet review pending  
Decision: [TH-DEC-0015](../decisions/0015-approved-sprint-12-completion-prerequisites-review.md)  
Scope: Disabled, synthetic-only, owner-bound and read-only structural-evidence review during unfinished wrap-up; no clinical-completeness decision, mutation, signing, finalization, patient delivery, downstream creation, lifecycle action, external call, or patient care

## 1. Implementation trace

| Item | Implementation | Evidence |
|---|---|---|
| `TH-SP12-001` | `TelehealthCompletionReviewRepository` rebinds the opaque consultation to the current owning physician, practice/facility, adult active patient, released reservation, ended room, wrap-up request/shift, in-progress appointment, and open unsigned encounter in one repeatable read | Owner/non-owner and administrator denial, signed-encounter denial, live PostgreSQL proof, and focused service authorization tests |
| `TH-SP12-002` | The projection returns only current SOAP version and section-presence booleans plus current structured disposition version/code/confirmation state; it returns no SOAP, authored disposition text, canonical key, actor identity, payer detail, patient demographic, or pharmacy identity/address | Typed contract and OpenAPI allowlist, initial/complete live states, source inspection, and browser excluded-content assertions |
| `TH-SP12-003` | Optional pharmacy choice reports version and patient-confirmation state only and never blocks; stable product blockers remain after structural evidence is present, and signing/completion/delivery/downstream capabilities are always false | Empty/full-state component tests, live transition proof, and exact JSON assertions |
| `TH-SP12-004` | A physician-scoped GET uses opaque not-found, private/no-store handling, consultation-correlated patient/encounter view audit, and no write permission | Authorization, audit/cache, OpenAPI, repeated-read, and signed-lock evidence |
| `TH-SP12-005` | The WrapUp-only panel labels the result as structural rather than clinical, supports manual reload and focused error recovery, has no mutation controls, reflows at 320 px, and persists no payload | Component tests and the complete desktop/mobile Chromium, Firefox, and WebKit accessibility/recovery matrix |
| `TH-SP12-006` | Safeguard `TH-SG-017`, Decision 0015, planning validation, Graphify review, runbook, full migration recovery, and complete regressions close the bounded evidence loop | Complete automated results below |

## 2. Automated results

| Gate | Result |
|---|---|
| ASP.NET Core Release build | Passed with 0 warnings and 0 errors |
| Full backend tests | 160 passed, 0 failed, 0 skipped |
| Focused telehealth backend tests | 107 passed, 0 failed, 0 skipped, including completion-review service authorization cases |
| C# format verification | Passed with no changes required |
| Frontend lint and TypeScript | Passed |
| Full frontend unit/component tests | 51 files, 241 tests passed; focused panel/API run passed 20 tests |
| Production frontend build and budget | Passed; 246,395 / 256,000 initial bytes; 137 JavaScript chunks checked |
| Cross-browser telehealth accessibility and recovery | 48 passed across desktop/mobile Chromium, Firefox, and WebKit; 44 accessibility journeys plus 4 stale-action recovery journeys |
| Full 245-migration empty/populated/interruption/recovery rehearsal | Passed 29 scenarios, including checkpoints 1, 64, and 127, bootstrap catch-up, idempotent replay, checksum-drift rejection, and unexpected-ledger rejection |
| Telehealth migration/schema regression | 37 passed; V0282–V0289, all 28 telehealth tables, 21 append-only triggers, and all earlier controls passed; Sprint 12 requires no schema change |
| Telehealth authorization proof | 34 passed, including absent-identity and administrator completion-review denial |
| Telehealth OpenAPI proof | 18 passed, including the typed, minimized, read-only completion-review contract and no finalization/downstream action |
| Telehealth runtime-safety proof | 13 top-level checks passed; its 10 focused runtime-policy tests also passed, including no completion mutation, downstream creation, or outbound path |
| Prospective identity regression | 11 passed, including contention and zero canonical deltas |
| Real-PostgreSQL end-to-end concurrency proof | 119 passed; initial/full completion-review states, owner/non-owner, repeated-read no-delta, signature lock, audit/cache/privacy, and all prior workflow controls passed |
| Seeded API readiness | Passed after 245 migrations; all 28 telehealth tables ready |
| Generated empty bootstrap verification | Passed unchanged; packaged bootstrap SHA-256 `6a1a6ca3de61608654921edb843d48a4b07dcc8899d3e6ca4056cf8b838745a2` |
| Planning/backlog validator | 57 passed across 66 Markdown files and 214 relative links; all three controlled negative mutations returned nonzero |
| Graphify code index | Refreshed to 6,742 nodes, 15,988 edges, and 348 communities; portable-artifact check passed |

Machine-readable runtime results are under `avenchart/artifacts/telehealth/`, with recovery evidence under `avenchart/artifacts/migration-resilience/`. They contain deterministic synthetic identifiers and coarse facts only. Database evidence ran in the isolated `avtelehealthsp1220260827` Compose project while the existing default PostgreSQL volume remained stopped and untouched.

After evidence capture, the exact labeled API container, Compose database container, network, and isolated volume were removed. That isolated synthetic dataset is intentionally not recoverable. The pre-existing default PostgreSQL service was restarted and verified unchanged at 237 migrations, 1,000 synthetic patients, and latest migration `V0281__index_flow_board_appointments_by_date`.

## 3. Safety, ownership, privacy, and UX results

The evidence demonstrates that:

- only the physician who owns the current unsigned unfinished wrap-up can read the projection; an administrator is forbidden, another physician receives opaque not-found, and a canonical locking signature removes eligibility;
- SOAP evidence is limited to version and nonblank section-presence booleans and is explicitly not represented as applicability, accuracy, review, adequacy, or clinical completeness;
- disposition evidence is limited to the current physician-selected code, version, and structured confirmation booleans, with no authored instructions, warnings, summaries, or other free text;
- optional pharmacy absence creates no blocker and presence reveals only version and patient-confirmation state;
- structural evidence can become present while final clinical review/signature and atomic downstream-ownership blockers remain, and every signing, completion, patient-delivery, and downstream capability remains false;
- repeated GETs append only their required view audits and create no clinical, signature, lifecycle, prescription, medication, financial, message, task, notification, integration, external-call, or browser-storage delta; and
- the browser focuses a failed load, recovers only after explicit reload, presents no finalization control, and keeps the response out of local and session storage.

## 4. Defects and boundary refinements found by the evidence gate

The first live non-owner and signed-encounter checks exposed an Npgsql lifecycle defect: the no-row branch attempted to commit while the reader was still open, turning the intended opaque 404 into a 500. The repository now disposes the reader before commit. The authoritative 119-check PostgreSQL run proves both paths return 404 and the complete workflow remains intact.

React StrictMode performs the development fetch effect twice. The initial browser failure mock failed only the first request, so the second effect succeeded before the explicit user reload and invalidated the recovery assertion. The proof now holds the completion-review route in failure until the user activates Reload; all four browser projects then passed, as did the complete 48-case run.

The full migration rehearsal was executed inside the labeled Sprint 12 Compose project. A later prospective-identity invocation initially omitted that project selector and found the intentionally stopped default service; it made no database call or data change. The selector was supplied and the authoritative 11-check run passed against the isolated synthetic environment.

The program owner authorized generated-bootstrap changes. Regeneration was unnecessary: direct verification and the complete 245-migration recovery rehearsal proved the committed bootstrap current and byte-identical.

## 5. Graph and change-impact review

The deterministic code-only Graphify index was rebuilt to 6,742 nodes, 15,988 edges, and 348 communities, and its portability check passed. A direct query did not surface the new Sprint 12 repository, endpoint contracts, panel, or focused tests, and `review-delta` reported zero changed or impacted nodes for the eight principal files because the entire telehealth feature remains new and untracked relative to the current commit. The query result was saved under `.graphify/memory/`. Generic missing-test hints were treated only as navigation prompts; the direct unit, API, browser, real-database, authorization, OpenAPI, runtime-safety, migration, and recovery evidence above covers those exact boundaries.

## 6. Negative assertions and exclusions

Sprint 12 does not authorize or claim a clinical-completeness policy, an affirmative ready-to-sign decision, generated chart content, diagnosis, coding, an order or referral, medication reconciliation or prescribing, a signed/final disposition, co-signature, patient instruction or AVS delivery, encounter/request/appointment completion, clinician release, billing, claims, messages, tasks, notifications, outbox work, real media, production enablement, real people, real PHI, or patient care.

## 7. Open review gates

Independent clinical-safety, security/privacy, data, accessibility, interoperability, legal/compliance, operational, and program-owner review remain open. Until those reviews are recorded, Sprint 12 remains a disabled synthetic development slice and every production and patient-care gate remains closed.
